Insights into the diagnosis and treatment of lysosomal storage diseases

被引:64
作者
Wenger, DA [1 ]
Coppola, S [1 ]
Liu, SL [1 ]
机构
[1] Jefferson Med Coll, Dept Neurol, Philadelphia, PA 19107 USA
关键词
D O I
10.1001/archneur.60.3.322
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Lysosomal storage diseases (LSDs) are a group of genetic disorders that result from defective lysosomal metabolism or export of naturally occurring compounds. Signs and symptoms are variable both within and between disorders depending on the location and extent of storage. Many patients develop neurologic symptoms that become obvious from the newborn period to adulthood. Diagnosis of suspected patients can usually be made by measuring the activity of an enzyme or concentration of a metabolite in easily obtained tissue samples. Based on the considerable diagnostic experience of our laboratory, we aid the physician in selecting the appropriate tests to perform. Hematopoietic stem cell transplantation and enzyme replacement therapy are already available or in clinical trials for a number of LSDs. Early diagnosis is critical, especially since those patients who are treated before significant symptoms arise have the best chance for a positive outcome.
引用
收藏
页码:322 / 328
页数:7
相关论文
共 26 条
  • [1] N-butyldeoxygalactonojirimycin:: A more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo
    Andersson, U
    Butters, TD
    Dwek, RA
    Platt, FM
    [J]. BIOCHEMICAL PHARMACOLOGY, 2000, 59 (07) : 821 - 829
  • [2] Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer
    Bosch, A
    Perret, E
    Desmaris, N
    Trono, D
    Heard, JM
    [J]. HUMAN GENE THERAPY, 2000, 11 (08) : 1139 - 1150
  • [3] Chamoles NA, 2001, CLIN CHEM, V47, P2098
  • [4] Chang MHY, 2000, CLIN CHEM, V46, P167
  • [5] Clarke Stephen, 2002, Br J Biomed Sci, V59, P42
  • [6] Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease.
    Eng, CM
    Guffon, N
    Wilcox, WR
    Germain, DP
    Lee, P
    Waldek, S
    Caplan, L
    Linthorst, GE
    Desnick, RJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) : 9 - 16
  • [7] Mammalian neural stem cells
    Gage, FH
    [J]. SCIENCE, 2000, 287 (5457) : 1433 - 1438
  • [8] Extensive β-glucuronidase activity in murine central nervous system after adenovirus-mediated gene transfer to brain
    Ghodsi, A
    Stein, C
    Derksen, T
    Yang, GY
    Anderson, RD
    Davidson, BL
    [J]. HUMAN GENE THERAPY, 1998, 9 (16) : 2331 - 2340
  • [9] GIESELMANN V, 1991, AM J HUM GENET, V49, P407
  • [10] ARYLSULFATASE-A PSEUDODEFICIENCY - LOSS OF A POLYADENYLYLATION SIGNAL AND N-GLYCOSYLATION SITE
    GIESELMANN, V
    POLTEN, A
    KREYSING, J
    VONFIGURA, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) : 9436 - 9440